★ Private Action
Eli Lilly pledges $27B in U.S. manufacturing under Trump
Corporate FavorsDrug Pricing Policy
Filed November 2025$27,000,000,000
★ The Brief
What happened
The pledge was announced in a White House fact sheet tied to Most-Favored-Nation drug pricing, the administration's framework for capping U.S. drug prices to international levels.
Who enabled it
Under the Trump administration, Eli Lilly announced at least $27 billion in new U.S. manufacturing investments, described in the White House fact sheet as occurring under President Trump's leadership. The investments are intended to expand domestic pharmaceutical manufacturing capacity.
Actors
Who pushed it · 1Who initiated, paid, or pushed the action.
- Eli Lilly
Announced at least $27 billion in new U.S. manufacturing investments, coinciding with the drug pricing agreement with the Trump administration.
Eli Lilly has paid into Trump’s orbit:
Further reading
- ★ Government ActionMay 2025Trump order targets U.S. drug prices to match other developed nations
- ★ Government ActionFebruary 2026Moroun lobbies Lutnick before Trump threatens Gordie Howe Bridge
- ★ Government ActionFebruary 2026Trump threatens to block Gordie Howe Bridge opening to punish Canada
- ★ Private ActionJanuary 2026Moroun donates $1M to MAGA Inc. before lobbying against rival bridge
- ★ Private ActionOctober 2025Amazon MGM pays $40M for Melania Trump documentary rights
- ★ Government ActionOctober 2025US government takes 10% equity stake in Trilogy Metals for $35.6M Ambler District investment